Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

PubWeight™: 2.51‹?› | Rank: Top 2%

🔗 View Article (PMID 6988135)

Published in Clin Pharmacokinet on June 16, 1980

Authors

J T Wilson, R D Brown, D R Cherek, J W Dailey, B Hilman, P C Jobe, B R Manno, J E Manno, H M Redetzki, J J Stewart

Articles citing this

The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol (2004) 1.74

Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure. Environ Health Perspect (2002) 1.61

Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect (2001) 1.05

Drugs taken by mothers in the puerperium: inpatient survey in Northern Ireland. Br Med J (Clin Res Ed) (1984) 1.00

Mexiletine in human blood and breast milk. Postgrad Med J (1981) 0.97

Effect of maternal antibiotics on breast feeding infants. Postgrad Med J (2004) 0.93

Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol (1990) 0.91

Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol (1984) 0.88

Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers. Br J Clin Pharmacol (1984) 0.85

Excretion of indomethacin in breast milk. Br J Clin Pharmacol (1991) 0.85

Drug treatment of epilepsy: a review. Can Med Assoc J (1983) 0.85

Terbutaline excretion into breast milk. Br J Clin Pharmacol (1982) 0.84

Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy. Eur Radiol (2014) 0.83

Antimicrobial therapy in neonates, infants and children. Clin Pharmacokinet (1989) 0.83

Statement on human milk banking. Nutrition Committee, Canadian Paediatric Society. Can Med Assoc J (1985) 0.82

Moclobemide excretion in human breast milk. Br J Clin Pharmacol (1990) 0.82

Clindamycin passage into human milk. Br J Clin Pharmacol (1982) 0.82

Excretion of chloroquine and desethylchloroquine in human milk. Br J Clin Pharmacol (1987) 0.80

Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol (1985) 0.80

Excretion of trazodone in breast milk. Br J Clin Pharmacol (1986) 0.78

Nitrofurantoin-induced cholestatic hepatitis from cow's milk in a teenaged boy. West J Med (1984) 0.78

Breastfeeding and antithyroid drugs: a view from within. Eur Thyroid J (2012) 0.76

The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol (1992) 0.76

Nefopam excretion in human milk. Br J Clin Pharmacol (1987) 0.75

Medical emergencies in the air. I: equipment and prevention. Br Med J (Clin Res Ed) (1983) 0.75

Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs. Indian J Pharmacol (2013) 0.75

Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog (1988) 0.75

Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects. Drugs (1986) 0.75

Articles by these authors

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91

Biotransformation of trichloroethylene in soil. Appl Environ Microbiol (1985) 6.75

Insertion of synthetic copies of human globin genes into bacterial plasmids. Nucleic Acids Res (1978) 5.99

Microbial ecology of the terrestrial subsurface. Adv Appl Microbiol (1988) 3.68

Human beta-globin messenger RNA. III. Nucleotide sequences derived from complementary DNA. J Biol Chem (1977) 3.55

Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15

Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma (1998) 2.81

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78

Direct identification of sickle cell anemia by blot hybridization. Proc Natl Acad Sci U S A (1981) 2.68

Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56

Accuracy of hospital discharge abstracts for identifying stroke. Stroke (1994) 2.53

White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology (2010) 2.49

Prospective hemorrhage risk of intracerebral cavernous malformations. Neurology (2012) 2.43

Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc (1997) 2.34

ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci (1978) 2.33

Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30

Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke (2001) 2.30

Relaxometry of brain: why white matter appears bright in MRI. Magn Reson Med (1990) 2.27

Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg (1995) 2.24

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther (2007) 2.17

Nucleotide sequence of the coding portion of human alpha globin messenger RNA. J Biol Chem (1980) 2.07

Equivalence of microbial biomass measures based on membrane lipid and cell wall components, adenosine triphosphate, and direct counts in subsurface aquifer sediments. Microb Ecol (1988) 2.02

Nucleotide sequence of 3' untranslated portion of human alpha globin mRNA. Nucleic Acids Res (1977) 1.92

Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology (1998) 1.92

Mass culture of hydra: an improved method and its application to other aquatic invertebrates. Lab Anim (1970) 1.91

AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke (2001) 1.84

Utilization of acute care services in the year before and after first stroke: A population-based study. Neurology (1996) 1.77

Prestroke physical activity and early functional status after stroke. J Neurol Neurosurg Psychiatry (2009) 1.73

Neurologic complications after placement of cerebrospinal fluid drainage catheters and needles in anesthetized patients: implications for regional anesthesia. Mayo Perioperative Outcomes Group. Anesth Analg (1999) 1.68

Impulsivity and history of drug dependence. Drug Alcohol Depend (1998) 1.66

The nucleotide sequence adjoining the 3' end of the genes coding for oocyte-type 5 S ribosomal RNA in Xenopus. J Mol Biol (1976) 1.63

Responding maintained by the opportunity to attack during an interval food reinforcement schedule. J Exp Anal Behav (1973) 1.62

Characterization of endo-1,4-beta-D-glucanases purified from Trichoderma viride. Biochim Biophys Acta (1978) 1.61

Conservation of the rifamycin sensitivity of transcription during T4 development. Nature (1969) 1.53

Use of biotinylated probes for detecting sickle cell anemia. Clin Chem (1985) 1.50

Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation. Neurosurgery (1994) 1.49

Clinical pharmacokinetics in infants and children. Clin Pharmacokinet (1976) 1.49

Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther (2007) 1.46

Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45

Sequences of 5S ribosomal RNA from Xenopus mulleri and the evolution of 5S gene-coding sequences. Cell (1976) 1.45

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr (1988) 1.44

Maintenance and stability of introduced genotypes in groundwater aquifer material. Appl Environ Microbiol (1987) 1.44

Comparison of four purified extracellular 1,4-beta-D-glucan cellobiohydrolase enzymes from Trichoderma viride. Biochim Biophys Acta (1977) 1.41

Phenylbutazone-induced blood dyscrasias suspected in three dogs. Vet Rec (1980) 1.40

Lack of effect of respiratory syncytial virus infection on theophylline disposition in children. J Pediatr (1992) 1.39

Cystic duct insertion at ampulla as a cause for acute recurrent pancreatitis. Gastrointest Endosc (1998) 1.38

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37

Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics. Neurology (2009) 1.36

Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Ann Intern Med (1999) 1.36

Causes of death during acute asthma in children. Am J Dis Child (1974) 1.35

Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid. J Anal Toxicol (2001) 1.33

Depression--a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol (1983) 1.33

The bgl1 gene encoding extracellular beta-glucosidase from Trichoderma reesei is required for rapid induction of the cellulase complex. Mol Microbiol (1992) 1.32

Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs. Annu Rev Pharmacol Toxicol (1985) 1.31

Acetazolamide and symptomatic metabolic acidosis in mild renal failure. Br Med J (Clin Res Ed) (1981) 1.29

Tophaceous gout of the spine mimicking epidural infection: case report and review of the literature. Neurosurgery (2001) 1.29

Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J Anal Toxicol (1995) 1.28

Enzymic activities of endo-1,4-beta-D-glucanases purified from Trichoderma viride. Biochim Biophys Acta (1978) 1.28

Use of restriction endonucleases for mapping the allele for beta s-globin. Proc Natl Acad Sci U S A (1982) 1.26

Clinical and radiographic features of dural arteriovenous fistula, a treatable cause of myelopathy. Mayo Clin Proc (2001) 1.26

Human globin messenger RNA: importance of cloning for structural analysis. Science (1977) 1.25

Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia (2010) 1.25

Schedule-induced aggression as a function of fixed-ratio value. J Exp Anal Behav (1970) 1.25

The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery (1998) 1.24

Assessing disability after head injury: improved use of the Glasgow Outcome Scale. J Neurosurg (1998) 1.24

Subchronic 10 day immunotoxicity of polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol (1994) 1.23

Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man. Eur J Clin Pharmacol (1976) 1.23

Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation (1999) 1.22

Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab (1973) 1.20

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. J Pediatr (1982) 1.19

Anomalous relaxation of water protons in solutions of copper-containing proteins. Ann N Y Acad Sci (1973) 1.19

Magnetic field dependence of 1/T1 of protons in tissue. Invest Radiol (1985) 1.19

Dolichoectasia of the intracranial arteries in patients with first ischemic stroke: a population-based study. Neurology (1998) 1.16

A unified view of relaxation in protein solutions and tissue, including hydration and magnetization transfer. Magn Reson Med (1993) 1.15

Primary CNS vasculitis with spinal cord involvement. Neurology (2008) 1.15

Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment. Gastroenterology (1986) 1.15

Kinetics of carbamazepine and its 10,11-epoxide metabolite in children. Clin Pharmacol Ther (1976) 1.15

Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) (2008) 1.15

Saline injection needle-knife sphincterotomy: a preliminary report. Endoscopy (1996) 1.15

Partial sequence analysis of Xenopus alpha- and beta-globin mRNA as determined from recombinant DNA plasmids. Dev Biol (1980) 1.14

Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr (1999) 1.14

Carotid artery: elliptic centric contrast-enhanced MR angiography compared with conventional angiography. Radiology (2001) 1.14

Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. Cephalalgia (1999) 1.14

Reye syndrome and aspirin use: the role of prodromal illness severity in the assessment of relative risk. Pediatrics (1982) 1.14

Toxicology of ipecac: a review. Clin Toxicol (1977) 1.13

Chemical and enzymatic properties of riboflavin analogues. Biochemistry (1978) 1.12

Toxicology studies of a chemical mixture of 25 groundwater contaminants. I. Chemistry development. Fundam Appl Toxicol (1989) 1.12

Pharmacokinetics of Erythromycin in man. Antibiot Chemother (1971) (1978) 1.12

H 2 CO 3 as substrate for carbonic anhydrase in the dehydration of HCO 3 . Proc Natl Acad Sci U S A (1972) 1.12

Efficacy, disposition and pharmacodynamics of aspirin, acetaminophen and choline salicylate in young febrile children. Ther Drug Monit (1982) 1.12

Hypermethylation of E-cadherin in leukemia. Blood (2000) 1.12